Clinical Trial Update: Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options [Phase 1, Phase 2]

View source ↗

Summary

Ongoing pediatric study of entrectinib (Rxdx-101) for locally advanced or metastatic solid tumors and/or primary CNS tumors with no satisfactory treatment optio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumors
• Solid Tumors

Drugs mentioned

• Entrectinib (entrectinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Solid Tumors, CNS Tumors | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING